Browse by UCL people
Group by: Type | Date
Number of items: 10.
Article
Garcia-Moreno, Hector;
Langbehn, Douglas R;
Abiona, Adesoji;
Garrood, Isabel;
Fleszar, Zofia;
Manes, Marta Antonia;
Morley, Ana M Susana;
... Giunti, Paola; + view all
(2023)
Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.
Brain
, 146
(12)
pp. 5044-5059.
10.1093/brain/awad266.
|
Garcia-Moreno, Hector;
Prudencio, Mercedes;
Thomas-Black, Gilbert;
Solanky, Nita;
Jansen-West, Karen R;
Hanna Al-Shaikh, Rana;
Heslegrave, Amanda;
... Giunti, Paola; + view all
(2022)
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
European Journal of Neurology
, 29
(8)
pp. 2439-2452.
10.1111/ene.15373.
|
Garcia-Moreno, H;
Fassihi, H;
Sarkany, RPE;
Phukan, J;
Warner, T;
Lehmann, AR;
Giunti, P;
(2018)
Xeroderma pigmentosum is a definite cause of Huntington's disease-like syndrome.
Annals of Clinical and Translational Neurology
, 5
(1)
pp. 102-108.
10.1002/acn3.511.
|
Palacios-Cena, D;
Neira-Martin, B;
Silva-Hernandez, L;
Mayo-Canalejo, D;
Florencio, LL;
Fernandez-de-las-Penas, C;
Garcia-Moreno, H;
... Luz Cuadrado, M; + view all
(2017)
Living with chronic migraine: a qualitative study on female patients' perspectives from a specialised headache clinic in Spain.
BMJ Open
, 7
(8)
, Article e017851. 10.1136/bmjopen-2017-017851.
|
Prudencio, M;
Garcia-Moreno, H;
Jansen-West, KR;
Al-Shaikh, RH;
Gendron, TF;
Heckman, MG;
Spiegel, MR;
... Petrucelli, L; + view all
(2020)
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.
Science Translational Medicine
, 12
(566)
, Article eabb7086. 10.1126/scitranslmed.abb7086.
|
Scarabino, Daniela;
Veneziano, Liana;
Fiore, Alessia;
Nethisinghe, Suran;
Mantuano, Elide;
Garcia-Moreno, Hector;
Bellucci, Gianmarco;
... Giunti, Paola; + view all
(2022)
Leukocyte Telomere Length Variability as a Potential Biomarker in Patients with PolyQ Diseases.
Antioxidants
, 11
(8)
, Article 1436. 10.3390/antiox11081436.
|
Villar-Quiles, R-N;
Garcia-Moreno, H;
Mayo, D;
Gutierrez-Viedma, A;
Ramos, M-I;
Casas-Limon, J;
Cuadrado, M-L;
(2018)
Infratrochlear neuralgia: A prospective series of seven patients treated with infratrochlear nerve blocks.
Cephalalgia
, 38
(3)
pp. 585-591.
10.1177/0333102417690493.
|
Wilke, C;
Haas, E;
Reetz, K;
Faber, J;
Garcia-Moreno, H;
Santana, MM;
van de Warrenburg, B;
... Synofzik, M; + view all
(2020)
Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.
EMBO Molecular Medicine
, Article e11803. 10.15252/emmm.201911803.
|
Zeitlberger, AM;
Thomas-Black, G;
Garcia-Moreno, H;
Foiani, M;
Heslegrave, AJ;
Zetterberg, H;
Giunti, P;
(2018)
Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
Frontiers in Cellular Neuroscience
, 12
, Article 366. 10.3389/fncel.2018.00366.
|
Thesis
Garcia Moreno, Hector;
(2024)
Natural history and biomarkers in spinocerebellar ataxia type 3/Machado-Joseph disease and xeroderma pigmentosum.
Doctoral thesis (Ph.D), UCL (University College London).
|